Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GT160-246 for C. difficile-associated diarrhea
NCT00034294Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2002
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of tolevamer in Clostridioides difficile infection (CDI), sponsored by Sanofi. Started Feb 2002; status: completed.
02
Drugs
tolevamer
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT00034294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034294.